- Home
- Publications
- Publication Search
- Publication Details
Title
Component pathogen inactivation: a critical review
Authors
Keywords
-
Journal
VOX SANGUINIS
Volume 104, Issue 3, Pages 183-199
Publisher
Wiley
Online
2012-11-08
DOI
10.1111/j.1423-0410.2012.01662.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic efficacy of platelet components treated with amotosalen and ultraviolet A pathogen inactivation method: results of a meta-analysis of randomized controlled trials
- (2012) J. Cid et al. VOX SANGUINIS
- Safety and clinical efficacy of platelet components prepared with pathogen inactivation in routine use for thrombocytopenic patients
- (2011) Peter Schlenke et al. ANNALS OF HEMATOLOGY
- Anaphylactic reaction after methylene blue-treated plasma transfusion
- (2011) P. Dewachter et al. BRITISH JOURNAL OF ANAESTHESIA
- Evaluation of platelet transfusion clinical trials - response to Corash & Sherman
- (2011) Jean-Louis H. Kerkhoffs BRITISH JOURNAL OF HAEMATOLOGY
- Evaluation of platelet transfusion clinical trials
- (2011) Laurence Corash et al. BRITISH JOURNAL OF HAEMATOLOGY
- A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion
- (2011) Miguel Lozano et al. BRITISH JOURNAL OF HAEMATOLOGY
- Preclinical pharmacokinetic and toxicology assessment of red blood cells prepared with S-303 pathogen inactivation treatment
- (2011) Anne North et al. TRANSFUSION
- In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet light-treated whole blood
- (2011) Jose A. Cancelas et al. TRANSFUSION
- The hemostatic efficacy of platelet components prepared with pathogen inactivation
- (2011) Laurence Corash TRANSFUSION
- In reply
- (2011) Raymond P. Goodrich TRANSFUSION
- Cesium cessation? An advantage of pathogen reduction treatments
- (2011) Paul D. Mintz TRANSFUSION
- Stored red blood cell viability is maintained after treatment with a second-generation S-303 pathogen inactivation process
- (2011) Jose A. Cancelas et al. TRANSFUSION
- Pathogen-inactivation of platelet components with the INTERCEPT Blood System™: A cohort study
- (2011) Laura Infanti et al. TRANSFUSION AND APHERESIS SCIENCE
- Development of the S-303 Pathogen Inactivation Technology for Red Blood Cell Concentrates
- (2011) Reinhard Henschler et al. TRANSFUSION MEDICINE AND HEMOTHERAPY
- Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light
- (2011) Susanne Marschner et al. TRANSFUSION MEDICINE AND HEMOTHERAPY
- Main Properties of the THERAFLEX MB-Plasma System for Pathogen Reduction
- (2011) Jerard Seghatchian et al. TRANSFUSION MEDICINE AND HEMOTHERAPY
- Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood SystemTM
- (2011) Johannes Irsch et al. TRANSFUSION MEDICINE AND HEMOTHERAPY
- UVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma
- (2011) Axel Seltsam et al. TRANSFUSION MEDICINE AND HEMOTHERAPY
- Meta-analysis of the studies of bleeding complications of platelets pathogen-reduced with the Intercept system
- (2011) E. C. Vamvakas VOX SANGUINIS
- Establishment of the first International Repository for Transfusion-Relevant Bacteria Reference Strains: ISBT Working Party Transfusion-Transmitted Infectious Diseases (WP-TTID), Subgroup on Bacteria
- (2011) M. Störmer et al. VOX SANGUINIS
- Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products
- (2010) Raymond P. Goodrich et al. BIOLOGICALS
- Dose of Prophylactic Platelet Transfusions and Prevention of Hemorrhage
- (2010) Sherrill J. Slichter et al. NEW ENGLAND JOURNAL OF MEDICINE
- An active hemovigilance program characterizing the safety profile of 7483 transfusions with plasma components prepared with amotosalen and UVA photochemical treatment
- (2010) Jean-Pierre Cazenave et al. TRANSFUSION
- Kills 99% of known germs
- (2010) Chris V. Prowse et al. TRANSFUSION
- Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3-year period
- (2010) Jean-Pierre Cazenave et al. TRANSFUSION
- Meta-analysis of the randomized controlled trials of the hemostatic efficacy and capacity of pathogen-reduced platelets
- (2010) Eleftherios C. Vamvakas TRANSFUSION
- White blood cell inactivation after treatment with riboflavin and ultraviolet light
- (2010) Susanne Marschner et al. TRANSFUSION
- Defining “adequate” pathogen reduction performance for transfused blood components
- (2010) Raymond P. Goodrich et al. TRANSFUSION
- A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology
- (2010) J-P. Cazenave et al. TRANSFUSION
- The cost-effectiveness of pathogen reduction technology as assessed using a multiple risk reduction model
- (2010) Brian Custer et al. TRANSFUSION
- The extent of amotosalen photodegradation during photochemical treatment of platelet components correlates with the level of pathogen inactivation
- (2010) Weiqun Liu et al. TRANSFUSION
- Anaphylactic shock to fresh-frozen plasma inactivated with methylene blue
- (2010) Karine Nubret et al. TRANSFUSION
- In vitro assessment of apheresis and pooled buffy coat platelet components suspended in plasma and SSP+ photochemically treated with amotosalen and UVA for pathogen inactivation (INTERCEPT Blood System™)
- (2010) P. Chavarin et al. VOX SANGUINIS
- Monitoring photochemical pathogen inactivation treatment using amotosalen and ultraviolet-A light: evaluation of an indicator label
- (2010) H. Isola et al. VOX SANGUINIS
- Treatment of whole blood (WB) and red blood cells (RBC) with S-303 inactivates pathogens and retains in vitro quality of stored RBC
- (2009) N.A. Mufti et al. BIOLOGICALS
- Evaluation of in vitro storage properties of prestorage pooled whole blood-derived platelets suspended in 100 percent plasma and treated with amotosalen and long-wavelength ultraviolet light
- (2009) Stephen J. Wagner et al. TRANSFUSION
- Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use
- (2009) Jean Claude Osselaer et al. TRANSFUSION
- Assessment of safety in neonates for transfusion of platelets and plasma prepared with amotosalen photochemical pathogen inactivation treatment by a 1-month intravenous toxicity study in neonatal rats
- (2009) Vic Ciaravino et al. TRANSFUSION
- Cell viability during platelet storage in correlation to cellular metabolism after different pathogen reduction technologies
- (2009) Susanne M. Picker et al. TRANSFUSION
- Emerging infectious disease agents and their potential threat to transfusion safety
- (2009) Susan L. Stramer et al. TRANSFUSION
- BLOOD COMPONENTS: Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentrates
- (2009) Daniel R. Ambruso et al. TRANSFUSION
- Research opportunities for pathogen reduction/inactivation of blood components: summary of an NHLBI workshop
- (2009) Harvey G. Klein et al. TRANSFUSION
- Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion
- (2009) Patrice Rasonglès et al. TRANSFUSION
- Sterilization of platelet concentrates at production scale by irradiation with short-wave ultraviolet light
- (2009) Harald Mohr et al. TRANSFUSION
- BLOOD COMPONENTS: A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light
- (2009) Harald Mohr et al. TRANSFUSION
- Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: Results of a three-arm in vitro study
- (2009) Susanne M. Picker et al. TRANSFUSION AND APHERESIS SCIENCE
- Solvent-detergent filtered (S/D-F) fresh frozen plasma and cryoprecipitate minipools prepared in a newly designed integral disposable processing bag system
- (2009) M. El-Ekiaby et al. TRANSFUSION MEDICINE
- Properties of Pathogen-Inactivated Plasma Components
- (2009) Christopher Prowse TRANSFUSION MEDICINE REVIEWS
- Study of coagulation function in thawed apheresis plasma for photochemical treatment by amotosalen and UVA
- (2009) N. de Valensart et al. VOX SANGUINIS
- Methylene blue-photoinactivated plasmaversusquarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study
- (2008) Julio del Río-Garma et al. BRITISH JOURNAL OF HAEMATOLOGY
- A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment
- (2008) Jean C. Osselaer et al. TRANSFUSION
- Spore-forming organisms in platelet concentrates: a challenge in transfusion bacterial safety
- (2008) M. Störmer et al. TRANSFUSION MEDICINE
- Epidemiology of Transfusion Related Acute Lung Injury in France: Preliminary Results
- (2008) Philippe Renaudier et al. TRANSFUSION MEDICINE AND HEMOTHERAPY
- Toxicity Testing of a Novel Riboflavin-Based Technology for Pathogen Reduction and White Blood Cell Inactivation
- (2008) Heather L. Reddy et al. TRANSFUSION MEDICINE REVIEWS
- ADAMTS-13 activity and von Willebrand factor levels in methylene blue photo-inactivated plasma processed by either the Springe method or an in house system
- (2008) J. del Ro-Garma et al. VOX SANGUINIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started